mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals [electronic resource] / an interview with E. John Wherry.
Material type:![Sound](/opac-tmpl/lib/famfamfam/MU.png)
Audio interview.
Title from title frames.
Contents: Monitoring the levels of immune cells, e.g. memory B cells, rather than levels of antibodies, as an indication of long term immune protection -- The efficacy of vaccines in previously infected vs previously uninfected individuals -- The efficacy of a single vs double dose -- The potential value of administrating a "booster" that is different from the previous administered vaccine in an individual, AKA "mixing-and-matching".
Access restricted to subscribers.
Mode of access: World Wide Web.